CardioExchange Archive

December 11th, 2013

Inside The KDIGO Guideline On Lipid Management In Patients With CKD

Marcello Tonelli, MD, SM and Harlan M. Krumholz, MD, SM

Recently the Kidney Disease Improving Global Outcomes (KDIGO) Lipid Management in Patients with Chronic Kidney Disease Guideline was published in Kidney International. Now a synopsis has appeared in the Annals of Internal Medicine. Harlan Krumholz spoke with the co-chairman of the guideline, Marcello Tonelli. Krumholz: Like the new US Guidelines, the KDIGO Guideline abandons targets. Were you aware of the US Guidelines or did […]

---

June 3rd, 2013

Waiting For ATP IV In Las Vegas

Reva Balakrishnan, MD, MPH

May 31– Today was the first full day of the National Lipid Association meeting in Las Vegas, Nevada. As a first time attendee, I notice many differences compared to the larger meetings. Firstly, there are ~ 700 people in attendance; this dwarfs in comparison to the AHA and ACC which count attendees in the thousands. […]

---

November 12th, 2012

Nonfasting Lipid Testing Gains Growing Acceptance

Larry Husten, PHD

Although fasting before a lipid test has long been recommended, a new study and accompanying commentaries make the case that nonfasting lipid levels are acceptable and may even be superior to fasting levels for the assessment of cardiovascular risk. Investigators at the University of Calgary analyzed data from laboratory tests obtained from more than 200,000 people […]

---

October 22nd, 2012

Selections from Richard Lehman’s Literature Review: October 22nd

Richard Lehman, BM, BCh, MRCGP

This week’s topics include favorable lipid-level trends in U.S. adults, an angiotensin receptor neprilysin inhibitor for patients with HF and preserved systolic ejection fraction, and a long-term safety comparison of the Zotarolimus-eluting and Sirolimus-eluting coronary stents.

---

August 13th, 2012

Universal Screening for Dyslipidemia in Children: A Debate with Equipoise, but Tarnished by Industry Influence

William O Roberts, MD, MS

James H. Stein, MD sounds a clarion about the influence of the medical industry on the debate over whether children should be universally screened for dyslipidemia, as recommended by recent guidelines.

---

August 7th, 2012

Survey Finds Significant Drop in Cholesterol Levels in Youths

Larry Husten, PHD

New data from the National Health and Nutrition Examination Survey (NHANES), published in JAMA, show significant and perhaps surprising  improvements over the last 20 years in the lipid profile of youths aged 6-19 years. Among the key lipid parameters measured by the survey from 1988-1994 to 2007-2010: Total cholesterol decreased from 165 mg/dL to 160 mg/dL (p<0.001) Prevalence of […]

---